« Previous
Next »
Transplantation Proceedings
Volume 32, Issue 1,
Supplement 1
, Pages 6-8
, February 2000
Mycophenolate mofetil monotherapy: an example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients
References
-
.
Transplantation. 1998;66,1:44
- . Transplant Proc. 1998;30:1580
- Transplantation. 1997;64:1706
- Transplantation. 1997;63:1530
- Transplant Proc. 1998;30:1190
- . Transplant Proc. 1998;30:1194
-
Grinyo JM, Gil-Vernet S, Seron D, et al: Abstract 164, Int Congress on Immunosuppression, Orlando, 1997
-
Grinyo JM for the Daclizumab/MMF Combination Renal Transplant Study Group: Abstract 202, XVII World Congress of the Transplantation Society, Montreal, 1998
-
van Gelder T, de Kuiper R, van Besouw N, et al: Abstract 1611, XVII World Congress of the Transplantation Society, Montreal, 1998
-
Houde I, Noel R, de Cotret R, et al: Abstract 1722, XVII World Congress of the Transplantation Society, Montreal, 1998
PII: S0041-1345(00)00808-3
© 2000 Elsevier Science Inc. All rights reserved.
« Previous
Next »
Transplantation Proceedings
Volume 32, Issue 1,
Supplement 1
, Pages 6-8
, February 2000
